Abstract
Membrane fusion and fission are two key processes that occur during the replication of enveloped viruses, namely access to the interior of the host-cell (entry, which requires fusion of the viral envelope with the target cell envelope) and dissemination of viral progeny after replication (egress, which involves budding and fission). These dynamic processes are mediated by specialized proteins that modify and bend the lipid bilayer transiently and locally. This review focuses on fusion and fission reactions and on the hypothetical shared mechanism that generates their driving force.
Keywords: Membrane fusion, membrane fission, glycoprotein, enveloped virus
Protein & Peptide Letters
Title: Membrane Fusion and Fission: Enveloped Viruses
Volume: 16 Issue: 7
Author(s): Annarita Falanga, Marco Cantisani, Carlo Pedone and Stefania Galdiero
Affiliation:
Keywords: Membrane fusion, membrane fission, glycoprotein, enveloped virus
Abstract: Membrane fusion and fission are two key processes that occur during the replication of enveloped viruses, namely access to the interior of the host-cell (entry, which requires fusion of the viral envelope with the target cell envelope) and dissemination of viral progeny after replication (egress, which involves budding and fission). These dynamic processes are mediated by specialized proteins that modify and bend the lipid bilayer transiently and locally. This review focuses on fusion and fission reactions and on the hypothetical shared mechanism that generates their driving force.
Export Options
About this article
Cite this article as:
Falanga Annarita, Cantisani Marco, Pedone Carlo and Galdiero Stefania, Membrane Fusion and Fission: Enveloped Viruses, Protein & Peptide Letters 2009; 16 (7) . https://dx.doi.org/10.2174/092986609788681760
DOI https://dx.doi.org/10.2174/092986609788681760 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Development of Oncolytic Adenovirus Therapy in the Past and Future - For the Case of Pancreatic Cancer
Current Cancer Drug Targets A QSAR Study on a Series of Indolin-2-Ones Acting as Non-Receptor Src Tyrosine Kinase Inhibitors
Letters in Drug Design & Discovery Anti-inflammatory Activity of Extra Virgin Olive Oil Polyphenols: Which Role in the Prevention and Treatment of Immune-Mediated Inflammatory Diseases?
Endocrine, Metabolic & Immune Disorders - Drug Targets Bladder Cancer and Stem Cells
Current Signal Transduction Therapy Progress Toward Vector Design for Hematopoietic Stem Cell Gene Therapy
Current Gene Therapy Current Status and Perspectives in Peptide Receptor Radiation Therapy
Current Pharmaceutical Design Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid Leukemia
Anti-Cancer Agents in Medicinal Chemistry Immunity to Tumour Antigens
Current Pharmaceutical Design Chemokine Contribution in Stem Cell Engraftment into the Infarcted Myocardium
Current Stem Cell Research & Therapy Biosafety of Onco-Retroviral Vectors
Current Gene Therapy Targeted Cancer Therapy: The Next Generation of Cancer Treatment
Current Drug Discovery Technologies PET Molecular Imaging of Hypoxia in Ischemic Stroke: An Update
Current Vascular Pharmacology Mesenchymal Stem Cell Therapy for Equine Tendinitis
Recent Patents on Regenerative Medicine Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part I
Inflammation & Allergy - Drug Targets (Discontinued) Therapeutic Strategies for Targeting BRAF in Human Cancer
Reviews on Recent Clinical Trials Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents
Current Medicinal Chemistry The Circulating Endothelial Cell in Cancer: Towards Marker and Target Identification
Current Pharmaceutical Design Imaging of Tumor Angiogenesis: Current Approaches and Future Prospects
Current Pharmaceutical Design Therapeutic Targets in Polycystic Liver Disease
Current Drug Targets The Renin Angiotensin System in the Regulation of Angiogenesis
Current Pharmaceutical Design